Br. Rose et al., SEQUENCE VARIATION IN THE UPSTREAM REGULATORY REGION OF HPV-18 ISOLATES FROM CERVICAL CANCERS, Gynecologic oncology, 66(2), 1997, pp. 282-289
This study describes sequence variation in both the enhancer and promo
ter segments of the upstream regulatory region (URR) of 28 human papil
lomavirus (HPV) type 18 isolates from cervical cancers, 25 from women
treated at an Australian center and three from overseas included for c
omparison. No large-scale changes were found in either region. Fourtee
n substitutions were identified in the enhancer region with the number
in individual isolates ranging from one to eight. Four substitutions
impacted cellular transcription factor binding sites but there were no
obvious associations with clinicopathological variables. The promoter
segment was found to be more highly conserved than the enhancer, but
four of the five point mutations identified involved cellular transcri
ption factor binding motifs including a substitution of C for T at nt
104 which affected 21 samples. This change was found to impact upon a
previously unrecognized Yin Yang (YY1) binding site. Electrophoretic m
obility shift assays (EMSA) showed that this substitution significantl
y reduced protein-DNA binding and evidence was sought for its possible
clinical implications. Of the 24 women with less than Stage III disea
se and known clinical outcome, tumor recurrence was observed in all of
the 6 women whose isolates had the ''prototype'' T at nt 104, whereas
only 8 of the 18 cancers with the mutation at this YY1 site recurred.
This is the first report on URR variation in HPV 18 isolates from the
South Pacific region. The study also provides initial data on diversi
ty in the promoter region and preliminary evidence suggesting that a s
pecific point mutation in this region may be clinically significant. (
C) 1997 Academic Press.